Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Radient Restructured By A Planned Reverse Merger

The Future of the Radient Pharmaceuticals Shell


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116585354

Re: Radient Restructured By A Planned Reverse Merger

The company has made at the end of 2014 Onko-Sure DR-70 tumor markers domestic production license, and earlier this year the domestic sales of the exhibition ? business plans within three years to complete the major countries in Asia-Pacific (Japan, Korea, Australia, New Zealand, ASEAN countries, China to Turkey and more than twenty countries) of the market, taken the domestic market into the regional market and even the size of the global market.
Arima drugs combined number of expert consultants and research units, using the latest technology to Onko-Sure DR-70 continuous improvement, it is desirable to develop a second generation of rapid screening products or more precisely the Bead Assay products, but also about Arima binding Onko- the third generation of research reagents Sure combo with other tumor markers, the future will have the exclusive patent protection for these products are made and exclusive.

http://uni-pharma.com/news_detail-4.html


http://uni-pharma.com/news_overview.html

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

Combination of Tumor Markers with the developer under agreement with Radient until November 2015...Provista Diagnostics Inc......ahoooooooooooooooo


Arima drugs combined number of expert consultants and research units, using the latest technology to Onko-Sure DR-70 continuous improvement, it is desirable to develop a second generation of rapid screening products or more precisely the Bead Assay products, but also about Arima binding Onko-Sure the third generation of research reagents combo with other tumor markers, the future will have the exclusive patent protection for these products are made and exclusive.